Arrowhead Pharmaceuticals <ARWR.O>: Citigroup initiates coverage with buy rating; target price $108
ARWR•Related News
Ionis Pharmaceuticals, Inc. <IONS.O>: H.C. Wainwright cuts target price to $100 from $115
IONS•
MINISO files HKEX next-day disclosure return, reports share repurchase for cancellation
MNSO•
Quetta Acquisition Corp announces special shareholder meeting
QETA•
Fold Holdings enters USD 25 million unregistered equity facility with Roth Principal Investments
FLD•
Henry Schein to present at Baird Global Healthcare Conference
HSIC•